FIELD: medicine.
SUBSTANCE: invention refers to medicine, more specifically to ophthalmology, and is intended for surgical management of massive hyphema, occurring in the anterior chamber of eyeball after surgical interventions. Recombinant tissue plasminogen activator (TPA) in a dose of 25 mcg/0.1 ml is introduced into the anterior chamber. 40 minutes later after the introduction dissolved blood is washed by washing the anterior chamber by means of salt solution BSS, after that, TPA is introduced once more into the anterior chamber in the same dosage and the operation is completed.
EFFECT: method ensures successful resorption of massive hyphema for a shorter period and simultaneously ensures resolution of the blood clots which are behind the iris.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING ANTERIOR UVEITES OF ANIMALS AND BIRDS OF SEVERE SEVERITY | 2018 |
|
RU2706338C1 |
| PHARMACEUTICAL COMPOSITION ELICITING THROMBOLYTIC AND FIBRINOLYTIC EFFECT | 2002 |
|
RU2216348C1 |
| METHOD OF TREATING ANTERIOR UVEITIS OF ANIMALS AND BIRDS OF MILD AND MODERATE SEVERITY | 2018 |
|
RU2707279C1 |
| METHOD FOR SURGICAL MANAGEMENT OF SUBRETINAL HEMORRHAGES | 2018 |
|
RU2696923C1 |
| METHOD FOR PREVENTING COMPLICATIONS IN PERFORMING CAVITARY SURGICAL OPERATIONS ON EYES | 1994 |
|
RU2115398C1 |
| SURGERY TECHNIQUE FOR SUBRETINAL HAEMORRHAGES COMBINED WITH AGE-SPECIFIC MACULAR DYSTROPHY WITH SUBRETINAL NEOVASCULAR MEMBRANE | 2008 |
|
RU2366388C1 |
| METHOD OF TREATING INTRAOCULAR HEMORRHAGES | 0 |
|
SU1018634A1 |
| METHOD FOR TREATING HYPHEMIA | 1994 |
|
RU2102948C1 |
| METHOD FOR TREATING THE CASES OF HYPHEMA | 2000 |
|
RU2199985C2 |
| TREATMENT METHOD OF MASSIVE SUBMACULAR HEMORRHAGES | 2007 |
|
RU2342105C1 |
